新宿・代々木こころのラボクリニック
平日21時まで。

平成22年 American Psychiatric Association Research Colloquium for Junior Investigators

平成24年 American Society of Clinical Psychopharmacology Fellowship Award

平成25年 American Association for Geriatric Psychiatry Early Investigator Poster Award

平成25年 Society of Biological Psychiatry Travel Fellowship Award

平成25年 Asian Clinical Neuropsychophamarcology Travel Fellowship Award

平成26年 American Society of Clinical Psychopharmacology Annual Meeting New Investigator Award

平成26年 University of Toronto’s Best Accomplishment Fellow Award

平成26年 The International College of Geriatric Psychoneuropharmacology Young Investigator Award

平成27年 International Congress on Schizophrenia Research Young Investigator Travel Award

平成27年 American College of Neuropsychopharmacology travel award

平成27年 World Psychiatric Association International Congress Young Psychiatrist Award

平成28年 Schizophrenia International Research Society Conference’s travel award

平成28年 University of Toronto Department of Psychiatry’s Travel Award

平成28年 慶應義塾大学医学部三四会奨励賞

1.Nakajima S, Caravaggio F, Mamo D, Mulsant BH, Chung J, Plitman E, Iwata Y, Gerretsen P, Uchida H, Suzuki T, Mar W, Wilson A, Houle S, Graff-Guerrero A. Dopamine D2/3 Receptor Availability in the Striatum of Antipsychotic-Free Patients with Late-Life Schizophrenia - a cross-sectional [11C]-raclopride PET study. Schizophrenia Research. 2015 May;164(1-3):263-7.

2.Nakajima S, Caravaggio F, Boileau I, Chung J, Plitman E, Gerretsen P, Wilson A, Houle S, Mamo D, Graff-Guerrero A. Lack of Decrease in Dopamine D3 receptor Availability - [11C]-(+)-PHNO and [11C]-Raclopride Positron Emision Tomography Study. Journal of Cerebral Blood Flow & Metabolism. 2015 Nov;35(11):1812-8.

3.Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, Chavez S, Sawada S, Wada M, Matsui M, Fujii S, Miyazaki T, Chakravarty MM, Uchida H, Remington G, Graff-Guerrero A, Mimura M, Nakajima S. Levels of Glutamatergic Neurometabolites in Patients with Severe Treatment-Resistant Schizophrenia: A Proton Magnetic Resonance Spectroscopy Study. Neuropsychopharmacology. 2020 Mar;45(4):632-640.

4.Nakajima S, Uchida H, Suzuki T, Watanabe K, Hirano J, Yagihashi T, Takeuchi H, Abe T, Kashima H, Mimura M. Is Switching Antidepressants Following Early Nonresponse More Beneficial in Acute-Phase Treatment of Depression?: A Randomized Open-Label Trial. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1; 35(8):1983-1989.

5.Iwata Y, Nakajima S, Caravaggio F, Uchida H, Suzuki T, Plitman E, Mar W, Pollock B, Mulsant BH, Rajji TK, Mamo D, Graff-Guerrero A. Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients with Schizophrenia. J Clin Psychiatry. 2016 Dec;77(12):e1557-e1563.

6.Nakajima S, Caravaggio F, Mamo D, Mulsant BH, Chung J, Plitman E, Iwata Y, Gerretsen P, Uchida H, Suzuki T, Mar W, Wilson A, Houle S, Graff-Guerrero A. Dopamine D2/3 Receptor Availability in the Striatum of Antipsychotic-Free Patients with Late-Life Schizophrenia - a cross-sectional [11C]-raclopride PET study. Schizophrenia Research. 2015 May;164(1-3):263-7.

7.Nakajima S, Uchida H, Bies R, Caravaggio F, Suzuki T, Plitman E, Mar W, Pollock B, Mulsant B, Mamo D, Graff-Guerrero A. Predicting Dopamine D2 Receptor Occupancy Following Antipsychotic Dose Reduction. Schizophrenia Bulletin. 2016 Jan;42(1):212-9.

8.Graff-Guerrero A, Rajji T, Mulsant B, Nakajima S, Caravaggio F, Suzuki T, Uchida H, Gerretsen P, Mar W, Pollock B, Mamo D. Maintenance Antipsychotic Dose Can Be Decreased in Late-life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study with [11C]-raclopride. JAMA Psychiatry. 2015 Sep;72(9):927-34.

9.Nakajima S (co-first), Iwata Y, Suzuki T, Keefe R, Plitman E, Chung J, Caravaggio F, Masaru M, Graff-Guerrero A, Uchida H. Effect of glutamatergic modulators on cognitive impairment in schizophrenia ? systematic review and meta-analysis. Molecular Psychiatry. 2015 Oct;20(10):1151-60.

10.Nakajima S (co-first), Iwata Y, Plitman E, Caravaggio F, Kim J, Shah P, Mar W, Chavez S, De Luca V, Mimura M, Remington G, Gerretsen P, Graff-Guerrero A. Glutamatergic Neurometabolite Levels in Patients with Ultra Treatment-Resistant Schizophrenia: a Cross-sectional 3T Proton MRS study. Biological Psychiatry. 2018 Sep 26.

»もっと見る

平成30年 CINP's(International College of Neuropsychopharmacology) Best Poster Award

平成30年 JSBP's(Japanese Society of Biological Psychiatry) Excellent Presentation Award

令和元年 SOBP's(Society of Biological Psychiatry) Travel Award

令和2年 APA's(American Psychiatric Association) Junior Psychiatrist Investigators Award

1.Wada M, Mimura M, Noda Y, Takasu S, Plitman E, Honda M, Natsubori A, Ogyu K, Tarumi R, Graff-Guerrero A, Nakajima S. Neuroimaging Correlates of Narcolepsy with cataplexy: A Systematic Review. Neurosci Res. 2019 May;142:16-29.

2.Ogyu K, Kubo K, Noda Y, Iwata Y, Tsugawa S, Omura Y, Wada M, Tarumi R, Plitman E, Moriguchi S, Miyazaki T, Uchida H, Graff-Guerrero A, Mimura M, Nakajima S: Kynurenine Pathway in Depression: A Systematic Review and Meta-analysis. Neurosci Biobehav Rev. 2018 Jul;90:16-25.

3.Wada M, Noda Y, Shinagawa S, Chung JK, Sawada K, Ogyu K, Tarumi K, Tsugawa S, Miyazaki T, Yamagata B, Graff-Guerrero A, Mimura M, Nakajima S: Effect of education on Alzheimer’s disease-related neuroimaging biomarkers in healthy controls, and participants with mild cognitive impairment and Alzheimer’s disease - a cross-sectional study. J Alzheimers Dis. 2018;63(2):861-869.

4.Iimori T, Nakajima S, Miyazaki T, Tarumi R, Ogyu K, Wada M, Tsugawa S, Masuda F, Daskalakis ZJ, Blumberger DM, Mimura M, Noda Y. Effectiveness of the prefrontal repetitive transcranial magnetic stimulation on cognitive profiles in depression, schizophrenia, and Alzheimer’s disease: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jan 10;88:31-40.

5.Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, Plitman E, Sano Y, Tarumi R, ElSalhy M, Katayama N, Ogyu K, Miyazaki T, Kishimoto T, Graff-Guerrero A, Meyer JH, Blumberger DM, Daskalakis ZJ, Mimura M, Nakajima S. Glutamatergic Neurometabolite Levels in Major Depressive Disorder: A Systematic Review and Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies. Mol Psychiatry. 2018 Oct 12.

6.Masuda F, Nakajima S, Miyazaki T, Tarumi R, Ogyu K, Wada M, Tsugawa S, Croarkin PE, Mimura M, Noda Y. Clinical effectiveness of repetitive transcranial magnetic stimulation treatment in children and adolescents with neurodevelopmental disorders: A systematic review. Autism. 2019 Jan 20:1362361318822502.

7.Masuda F, Nakajima S, Miyazaki T, Yoshida K, Tsugawa S, Wada M, Ogyu K, Croarkin PE, Blumberger DM, Daskalakis ZJ, Mimura M, Noda Y. Motor cortex excitability and inhibitory imbalance in autism spectrum disorder assessed with transcranial magnetic stimulation: a systematic review. Transl Psychiatry. 2019 Mar 7;9(1):110.

8.Wada M, Kurose S, Miyazaki T, Nakajima S, Masuda F, Mimura Y, Nishida H, Ogyu K, Tsugawa S, Mashima Y, Plitman E, Chakravarty MM, Mimura M, Noda Y. The P300 event-related potential in bipolar disorder: A systematic review and meta-analysis. J Affect Disord. 2019 Jun 4;256:234-249.

9.Noda Y, Barr MS, ElSalhy M, Masuda F, Tarumi R, Ogyu K, Wada M, Tsugawa S, Miyazaki T, Nakajima S, Mimura M. Neural correlates of delay discount alterations in addiction and psychiatric disorders: A systematic review of magnetic resonance imaging studies. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Nov 18:109822.

10.Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, Chavez S, Sawada K, Wada M, Matsui M, Fujii S, Miyazaki T, Chakravarty MM, Uchida H, Remington G, Graff-Guerrero A, Mimura M, Nakajima S. Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology. 2019 Dec 16. doi: 10.1038/s41386-019-0589-z.

1.Yoshida K, Mimura Y, Ishihara R, Nishida H, Komaki Y, Minakuchi T, Tsurugizawa T, Mimura M, Okano H, Tanaka KF, Takata N. Physiological effects of a habituation procedure for functional MRI in awake mice using a cryogenic radiofrequency probe. J Neurosci Methods. 2016 Dec 1;274:38-48.

2.三村 悠, 荻野 聡之, 高田 武人, 三村 将, 船山 道隆. 麻痺性イレウスを契機とした低カリウム血症加療中にたこつぼ型心筋症を合併した統合失調症の一例 -統合失調症と腸管- 栃木精神医学 第38 巻（2018) 32 - 39 頁.

3.Takashin Nakayama, Yu Mimura, Keita Hirano. Renal cortical hypoperfusion caused by glyphosate surfactant herbicide. Clin Exp Nephrol. 2019 Jan 19.

4.三村悠：摂食障害と神経心理学的所見. 神経心理学：35（4），207─214，2019.

5.S Kurose, Y Mimura, H Uchida, K Takahata, E Kim, T Suzuki, M Mimura, H Takeuchi: Dissociation in Pharmacokinetic Attenuation between Central Dopamine D2 Receptor Occupancy and Peripheral Blood Concentration of Antipsychotics: A Systematic review. Journal of Clinical Psychiatry. J Clin Psychiatry 2020;81(5):19r13113.

6.Mimura Y, Funayama M, Oi H1, Takata T, Takeuchi H, Mimura M. Effectiveness of Brexpiprazole in the Treatment in a Patient with Huntington's Disease. Psychiatry Clin Neurosci. 2020 Jan 13.

7. Yu Mimura, Shin Kurose, Taketo Takata, Hajime Tabuchi, Masaru Mimura and Michitaka Funayama. Pisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case report. BMC Neurology (2020) 20:183.

8. Michitaka Funayama; Yu Mimura, M.D.; Taketo Takata, M.D.; Akihiro Koreki, M.D., Ph.D; Satoyuki Ogino, M.D.; Shin Kurose, M.D. Body mass index and blood urea nitrogen to creatinine ratio predicts refeeding hypophosphatemia of anorexia nervosa patients with severe malnutrition. Journal of Eating Disorders. 2021 Jan 6;9(1):1.

9. Mimura Y, Nishida H, Nakajima S*, Tsugawa S, Morita S, Yoshida K, Tarumi R, Ogyu K, Wada M, Kurose S, Miyazaki T, Blumberger DM, Daskalakis ZJ, Chen R, Mimura M, Noda Y*, Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews, 2021 Feb;121:47-59.

10. Mimura Y, Shimizu Y, Oi H, Kurose S, Kudo S, Takata T, Mimura M, and Funayama M. “Case Series: Ischemic stroke associated with dehydration and arteriosclerosis in individuals with severe anorexia nervosa.” Journal of Eating Disorders, 2021 Mar 20;9(1):39.

11. Michitaka Funayama, Yu Mimura, Taketo Takata, Akihiro Koreki, Satoyuki Ogino, Shin Kurose, Yusuke Shimizu; Hypokalemia in patients with anorexia nervosa during refeeding is associated with binge-purge behavior, lower body mass index, and hypoalbuminemia. Journal of eating disorders, 2021 Aug 6;9(1):95.

12. Yu Mimura, Michitaka Funayama, Masaru Mimura. Combined abnormal findings of MRI-SPECT-EEG suggest vulnerability to ischemia in transient global amnesia. Journal of the neurological sciences, 2022 May 9;438:120273.

2020 Japanese Society of Clinical Neuropsychopharmacology’s Dr. Paul Janssen Research Award (As a co-first author)

1. Gamma‐aminobutyric acid (GABA) levels in the midcingulate cortex and clozapine response in patients with treatment‐resistant schizophrenia: A proton magnetic resonance … F Ueno, S Nakajima, Y Iwata, S Honda, E Torres‐Carmona, W Mar, ... Psychiatry and Clinical Neurosciences 76 (11), 587-594

2. Glutamatergic Neurometabolite Levels in Bipolar Disorder: A Systematic Review and Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies H Ino, S Honda, K Yamada, N Horita, S Tsugawa, K Yoshida, Y Noda, ... Biological Psychiatry: Cognitive Neuroscience and Neuroimaging

3. Reduced signal propagation elicited by frontal transcranial magnetic stimulation is associated with oligodendrocyte abnormalities in treatment-resistant depression M Wada, S Nakajima, S Honda, M Takano, K Taniguchi, S Tsugawa, ... Journal of Psychiatry and Neuroscience 47 (5), E325-E335

4. Patterns of functional connectivity alterations iduced by alcohol reflect somatostatin interneuron expression in the human cerebral cortex R Ochi, F Ueno, M Sakuma, H Tani, S Tsugawa, A Graff-Guerrero, ... Scientific Reports 12 (1), 1-9

5. DATA-DRIVEN DISEASE PROGRESSION PATTERNS OF BRAIN MORPHOLOGY IN SCHIZOPHRENIA: A MACHINE-LEARNING APPROACH D Sone, A Young, S Shinagawa, Y Noda, Y Iwata, R Tarumi, K Ogyu, ... AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY 56 (1_ SUPPL), 247-247

6. P549. MRI Neuromelanin Accumulation in Patients with Treatment-Resistant Schizophrenia: A Cross-Sectional Pilot Study F Ueno, Y Iwata, S Nakajima, S Chavez, F Caravaggio, G Horga, ... Biological Psychiatry 91 (9), S311

7. P548. Glymphatic System in Schizophrenia: An H-MRS High-Molecular-Weight Macromolecules Study A Abdolizadeh, ET Carmona, F Ueno, S Nakajima, R Tarumi, S Tsugawa, ... Biological Psychiatry 91 (9), S310-S311

8. P550. GABA Alteration in Patients With Treatment-Resistant Schizophrenia: A 1H-MRS Study F Ueno, S Nakajima, Y Iwata, S Honda, J Kim, F Caravaggio, E Brown, ... Biological Psychiatry 91 (9), S311

9. Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: a multi-atlas segmentation study T Takahashi, S Tsugawa, S Nakajima, E Plitman, MM Chakravarty, ... Schizophrenia Research 243, 268-275

10. Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment M Wada, Y Noda, Y Iwata, S Tsugawa, K Yoshida, H Tani, Y Hirano, ... Molecular Psychiatry, 1-18

»もっと見る